Table 4.
Characteristics at baseline for study participants
| Characteristics | albendazole | placebo |
|---|---|---|
| (N = 69) | (N = 81) | |
| Age (in years), mean (sd) | 28.38 (16.52) | 27.85 (16.91) |
| Sex, female, n(%) | 39 (56.52) | 45 (55.56) |
| Helminth Infections, n(%) | ||
| A. lumbricoides | 17 (24.64) | 18 (22.22) |
| Hookworm | 26 (37.681) | 23 (28.40) |
| N. americanus | 25 (36.23) | 23 (28.40) |
| A. duodenale | 2 (2.90) | 2 (2.47) |
| T. trichiura | 20 (28.99) | 22 (27.16) |
| Any helminths | 47 (68.12) | 47 (58.03) |
| Proportion (in %) of the 6 most abundant bacteria phyla, mean(sd) | ||
| Actinobacteria | 12.49 (8.95) | 10.96 (7.98) |
| Bacteroidetes | 7.41 (11.35) | 6.42 (11.04) |
| Firmicutes | 66.83 (13.46) | 70.05 (13.66) |
| Proteobacteria | 9.78 (7.86) | 9.16 (8.37) |
| Unclassified# | 1.95 (2.22) | 2.68 (3.22) |
| Pooled* | 1.54 (3.67) | 0.73 (1.22) |
#
Unclassified represents sequences that cannot be assigned to a phyla.
*
Pooled category consists of the remaining 13 phyla having average relative abundance among samples less than 1%.